Generation of prion transmission barriers by mutational control of amyloid conformations
暂无分享,去创建一个
[1] P. Lansbury,et al. Importance of seeding , 2005 .
[2] P. Lansbury,et al. Neurodegenerative disease: Amyloid pores from pathogenic mutations , 2002, Nature.
[3] F. Cohen,et al. Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.
[4] S. Prusiner,et al. A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain , 2002, Neuron.
[5] Alasdair C Steven,et al. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Weissman,et al. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers , 2002, Nature Structural Biology.
[7] Susan Lindquist,et al. Prions as protein-based genetic elements. , 2002, Annual review of microbiology.
[8] S. Prusiner,et al. Inherited prion disease caused by the V210I mutation , 2001, Neurology.
[9] S. Lindquist,et al. Strains of [PSI+] are distinguished by their efficiencies of prion‐mediated conformational conversion , 2001, The EMBO journal.
[10] D A Smith,et al. Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. , 2001, Journal of molecular biology.
[11] D. Melton,et al. Changing a single amino acid in the N‐terminus of murine PrP alters TSE incubation time across three species barriers , 2001, The EMBO journal.
[12] Yoshikazu Nakamura,et al. Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. , 2001, Molecular cell.
[13] C. King,et al. Supporting the structural basis of prion strains: induction and identification of [PSI] variants. , 2001, Journal of molecular biology.
[14] V. Smirnov,et al. [PSI+] prion generation in yeast: characterization of the ‘strain’ difference , 2001, Yeast.
[15] J. Weissman,et al. Conformational diversity in a yeast prion dictates its seeding specificity , 2001, Nature.
[16] C. Dobson. The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[17] J. Collinge. Their Causes and Molecular Basis , 2001 .
[18] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[19] M. Boguta,et al. Chaperones that cure yeast artificial [PSI +] and their prion-specific effects , 2000, Current Biology.
[20] J. Aiken,et al. Adaptation and Selection of Prion Protein Strain Conformations following Interspecies Transmission of Transmissible Mink Encephalopathy , 2000, Journal of Virology.
[21] Y. Chernoff,et al. Evolutionary conservation of prion‐forming abilities of the yeast Sup35 protein , 2000, Molecular microbiology.
[22] M. Ter‐Avanesyan,et al. Prion properties of the Sup35 protein of yeast Pichia methanolica , 2000, The EMBO journal.
[23] J. Weissman,et al. Molecular Basis of a Yeast Prion Species Barrier , 2000, Cell.
[24] D. Riesner,et al. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro. , 2000, Archives of virology. Supplementum.
[25] S. Lindquist,et al. The yeast non‐Mendelian factor [ETA+] is a variant of [PSI+], a prion‐like form of release factor eRF3 , 1999, The EMBO journal.
[26] J. Collinge,et al. Protease-resistant prion protein produced in vitro lacks detectable infectivity. , 1999, The Journal of general virology.
[27] J. Weissman,et al. A Critical Role for Amino-Terminal Glutamine/Asparagine Repeats in the Formation and Propagation of a Yeast Prion , 1998, Cell.
[28] K. Wüthrich,et al. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Lindquist,et al. Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI +], a Heritable Prion-like Factor of S. cerevisiae , 1997, Cell.
[30] Y. Chernoff,et al. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. , 1996, Genetics.
[31] P E Fraser,et al. A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.